Uso: Exclusivo para profesionales del sector esttico
Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, Ali F, Sholley C, Worrall C, et al
This study generated a metabolite model that could predict clinical outcomes, quantified by Therapy Intensity Level (TIL), in the initial and validation cohorts based on the levels of the ketogenic AA isoleucine, ketone bodies (-hydroxybutyrate and acetoacetate), medium chain fatty acids (dodecanoic acid, suberic acid, 2-hydroxyoctanoic acid), medium chain fatty acid derivatives (10-hydroxydecanoic acid, 8-hydroxyoctanoic acid), and butyrylcarnitine (Table 2) [46]
As research progresses, the applications and benefits of this combination therapy are likely to expand, making it a promising tool for patients aiming to achieve better metabolic health and vitality
Patients who took the full four weeks at each previous dose generally tolerate 10mg well